Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29282
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | van Poppel M.N.M. | en |
dc.contributor.author | Thangaratinam S. | en |
dc.contributor.author | Dunne F.P. | en |
dc.contributor.author | Devane D. | en |
dc.contributor.author | Biesty L.M. | en |
dc.contributor.author | Crowther C. | en |
dc.contributor.author | Egan A.M. | en |
dc.contributor.author | Bogdanet D. | en |
dc.contributor.author | Griffin T.P. | en |
dc.contributor.author | Kgosidialwa O. | en |
dc.contributor.author | Cervar-Zivkovic M. | en |
dc.contributor.author | Dempsey E. | en |
dc.contributor.author | Allotey J. | en |
dc.contributor.author | Alvarado F. | en |
dc.contributor.author | Clarson C. | en |
dc.contributor.author | Cooray S.D. | en |
dc.contributor.author | de Valk H.W. | en |
dc.contributor.author | Galjaard S. | en |
dc.contributor.author | Loeken M.R. | en |
dc.contributor.author | Maresh M.J.A. | en |
dc.contributor.author | Napoli A. | en |
dc.contributor.author | O'Shea P.M. | en |
dc.contributor.author | Wender-Ozegowska E. | en |
dc.date.accessioned | 2021-05-14T09:53:25Z | en |
dc.date.available | 2021-05-14T09:53:25Z | en |
dc.date.copyright | 2020 | en |
dc.date.created | 20200601 | en |
dc.date.issued | 2020-06-01 | en |
dc.identifier.citation | Diabetologia. 63 (6) (pp 1120-1127), 2020. Date of Publication: 01 Jun 2020. | en |
dc.identifier.issn | 0012-186X | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/29282 | en |
dc.description.abstract | Aims/hypothesis: The aim of this systematic review was to develop core outcome sets (COSs) for trials evaluating interventions for the prevention or treatment of gestational diabetes mellitus (GDM). Method(s): We identified previously reported outcomes through a systematic review of the literature. These outcomes were presented to key stakeholders (including patient representatives, researchers and clinicians) for prioritisation using a three-round, e-Delphi study. A priori consensus criteria informed which outcomes were brought forward for discussion at a face-to-face consensus meeting where the COS was finalised. Result(s): Our review identified 74 GDM prevention and 116 GDM treatment outcomes, which were presented to stakeholders in round 1 of the e-Delphi study. Round 1 was completed by 173 stakeholders, 70% (121/173) of whom went on to complete round 2; 84% (102/121) of round 2 responders completed round 3. Twenty-two GDM prevention outcomes and 30 GDM treatment outcomes were discussed at the consensus meeting. Owing to significant overlap between included prevention and treatment outcomes, consensus meeting stakeholders agreed to develop a single prevention/treatment COS. Fourteen outcomes were included in the final COS. These consisted of six maternal outcomes (GDM diagnosis, adherence to the intervention, hypertensive disorders of pregnancy, requirement and type of pharmacological therapy for hyperglycaemia, gestational weight gain and mode of birth) and eight neonatal outcomes (birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, neonatal hypoglycaemia, neonatal death and stillbirth). Conclusions/interpretation: This COS will enable future GDM prevention and treatment trials to measure similar outcomes that matter to stakeholders and facilitate comparison and combination of these studies. Trial registration: This study was registered prospectively with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/studies/details/686/.Copyright © 2020, The Author(s). | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Springer | en |
dc.relation.ispartof | Diabetologia | en |
dc.subject.mesh | clinical effectiveness | - |
dc.subject.mesh | birth | - |
dc.subject.mesh | birth weight | - |
dc.subject.mesh | Delphi study | - |
dc.subject.mesh | gestational age | - |
dc.subject.mesh | gestational weight gain | - |
dc.subject.mesh | hyperglycemia | - |
dc.subject.mesh | hypoglycemia | - |
dc.subject.mesh | large for gestational age | - |
dc.subject.mesh | maternal hypertension | - |
dc.subject.mesh | newborn | - |
dc.subject.mesh | patient compliance | - |
dc.subject.mesh | pregnancy diabetes mellitus | - |
dc.subject.mesh | premature labor | - |
dc.subject.mesh | small for date infant | - |
dc.subject.mesh | stillbirth | - |
dc.subject.mesh | antidiabetic agent | - |
dc.title | A core outcome set for studies of gestational diabetes mellitus prevention and treatment. | en |
dc.type | Article | en |
dc.identifier.affiliation | Diabetes and Vascular Medicine | - |
dc.type.studyortrial | Systematic review and/or meta-analysis | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s00125-020-05123-6 | - |
dc.publisher.place | Germany | en |
dc.identifier.pubmedid | 32193573 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32193573] | en |
dc.identifier.source | 2004570311 | en |
dc.identifier.institution | (Egan) Division of Endocrinology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, United States (Bogdanet, Griffin, Kgosidialwa, O'Shea, Dunne) School of Medicine, National University of Ireland Galway, Galway, Ireland (Griffin) Department of Endocrinology, St Vincent's University Hospital, Dublin, Ireland (Cervar-Zivkovic) Division of Obstetrics, Medizinische Universitat Graz, Graz, Austria (Dempsey, Devane) INFANT Centre and Department of Paediatrics & Child Health, University College Cork, Cork, Ireland (Allotey, Cooray, Thangaratinam) Barts Research Centre for Women's Health (BARC), Women's Health Research Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Alvarado) Mother Infant Research Institute, Tufts Medical Center, Boston, MA, United States (Clarson) Department of Pediatrics, University of Western Ontario, London, ON, Canada (Clarson) Lawson Health Research Institute, London, ON, Canada (Cooray) Diabetes and Vascular Medicine Unit, Monash Health, Melbourne, VIC, Australia (Cooray) Monash Centre for Health Research and Implementation, Monash University, Melbourne, VIC, Australia (de Valk) Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, Netherlands (Galjaard) Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, University Medical Centre Rotterdam, 's-Gravendijkwal 230, Rotterdam 3015 CE, Netherlands (Loeken) Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, United States (Loeken) Department of Medicine, Harvard Medical School, Boston, MA, United States (Maresh) Department of Obstetrics, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom (Napoli) Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza, University of Rome, Rome, Italy (Wender-Ozegowska) Department of Reproduction, Poznan University of Medical Sciences, Poznan, Poland (van Poppel) Institute of Sport Science, University of Graz, Graz, Austria (Thangaratinam) Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom (Crowther) Liggins Institute, The University of Auckland, Auckland, New Zealand (Biesty, Devane) School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland (Biesty, Devane) HRB-Trials Methodology Research Network, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland | en |
dc.description.address | A.M. Egan, Division of Endocrinology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, United States. E-mail: egan.aoife@mayo.edu | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2020 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Clinical diabetes Core outcome set Insulin therapy Pregnancy Systematic review | en |
dc.identifier.authoremail | Egan A.M.; egan.aoife@mayo.edu Galjaard S.; s.galjaard@erasmusmc.nl | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.